Td Waterhouse Canada Inc. Blueprint Medicines Corp Transaction History
Td Waterhouse Canada Inc.
- $12.3 Trillion
- Q3 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 21 shares of BPMC stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21Holding current value
$2,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$764 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$760 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$616 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$453 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$316 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.83B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...